Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080882 | SCV000112784 | benign | not specified | 2013-06-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000080882 | SCV000151566 | benign | not specified | 2013-07-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000456337 | SCV000562324 | benign | Spastic paraplegia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311601 | SCV000846525 | benign | Inborn genetic diseases | 2016-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001650915 | SCV001865624 | benign | not provided | 2020-12-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15586325, 24583395) |
Fulgent Genetics, |
RCV002477230 | SCV002803208 | likely benign | Syndromic X-linked intellectual disability Claes-Jensen type | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001650915 | SCV005279219 | benign | not provided | criteria provided, single submitter | not provided |